semaglutide and osa Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, sample baseline characteristics of the SURMOUNT -OSA phase 3 trial ADA 2026 - Semaglutide and

Food and Drug Administration (FDA) approved semaglutide in December 2017 under the brand name Ozempic for type 2 diabetes treatment

Use Proper Aseptic Technique: Proper storage is useless without proper handling

Strengthens Immune System: Provide antioxidant support to help your body defend against infections and illness

As regulatory agencies continue to monitor the safety and efficacy of these medications, the GLP-1 market is expected to grow significantly, potentially reaching $50 billion annually by 2030

Last reviewed: 29 May 2026

Explore presentation recordings from recent EASD Annual Meetings and our podcast series